Response to the letter from Dr Cosolo and Colleagues

por Pearson, A.D.J.
Publicado em 1992

Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin

por Meczes, E L, Pearson, A D J, Austin, C A, Tilby, M J
Publicado em 2002

Dose-related nephrotoxicity of carboplatin in children

por English, M W, Skinner, R, Pearson, A D J, Price, L, Wyllie, R, Craft, A W
Publicado em 1999

Two families with the Li-Fraumeni cancer family syndrome

por Pearson, A D J, Craft, A W, Ratcliffe, J M, Birch, J M, Morris-Jones, P, Roberts, D F
Publicado em 1982

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells

por Armstrong, J L, Ruiz, M, Boddy, A V, Redfern, C P F, Pearson, A D J, Veal, G J
Publicado em 2005

Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer

por Willits, I, Price, L, Parry, A, Tilby, M J, Ford, D, Cholerton, S, Pearson, A D J, Boddy, A V
Publicado em 2005

Estimation of glomerular filtration rate in paediatric cancer patients using (51)CR-EDTA population pharmacokinetics

por Cole, M, Price, L, Parry, A, Keir, M J, Pearson, A D J, Boddy, A V, Veal, G J
Publicado em 2004

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

por Matthay, K K, Shulkin, B, Ladenstein, R, Michon, J, Giammarile, F, Lewington, V, Pearson, A D J, Cohn, S L
Publicado em 2010

Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group

por Veal, G J, Cole, M, Errington, J, Pearson, A D J, Foot, A B M, Whyman, G, Boddy, A V
Publicado em 2007

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the Int...

por Beiske, K, Burchill, S A, Cheung, I Y, Hiyama, E, Seeger, R C, Cohn, S L, Pearson, A D J, Matthay, K K
Publicado em 2009

Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma

por Taylor, C P F, Bown, N P, McGuckin, A G, Lunec, J, Malcolm, A J, Pearson, A D J, Sheer, D
Publicado em 2000

Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours

por Veal, G J, Errington, J, Tilby, M J, Pearson, A D J, Foot, A B M, McDowell, H, Ellershaw, C, Pizer, B, Nowell, G M, Pearson, D G, Boddy, A V
Publicado em 2007

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

por Ambros, P F, Ambros, I M, Brodeur, G M, Haber, M, Khan, J, Nakagawara, A, Schleiermacher, G, Speleman, F, Spitz, R, London, W B, Cohn, S L, Pearson, A D J, Maris, J M
Publicado em 2009

A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin

por Veal, G J, Griffin, M J, Price, E, Parry, A, Dick, G S, Little, M A, Yule, S M, Morland, B, Estlin, E J, Hale, J P, Pearson, A D J, Welbank, H, Boddy, A V
Publicado em 2001

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group

por De Bernardi, B, Mosseri, V, Rubie, H, Castel, V, Foot, A, Ladenstein, R, Laureys, G, Beck-Popovic, M, de Lacerda, A F, Pearson, A D J, De Kraker, J, Ambros, P F, de Rycke, Y, Conte, M, Bruzzi, P, Michon, J
Publicado em 2008

A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation

por Estlin, E J, Pinkerton, C R, Lewis, I J, Lashford, L, McDowell, H, Morland, B, Kohler, J, Newell, D R, Boddy, A V, Taylor, G A, Price, L, Ablett, S, Hobson, R, Pitsiladis, M, Brampton, M, Clendeninn, N, Johnston, A, Pearson, A D J
Publicado em 2001

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project

por Schleiermacher, G, Mosseri, V, London, W B, Maris, J M, Brodeur, G M, Attiyeh, E, Haber, M, Khan, J, Nakagawara, A, Speleman, F, Noguera, R, Tonini, G P, Fischer, M, Ambros, I, Monclair, T, Matthay, K K, Ambros, P, Cohn, S L, Pearson, A D J
Publicado em 2012

Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

por Gaspar, N, Marshall, L V, Binner, D, Herold, R, Rousseau, R, Blanc, P, Capdeville, R, Carleer, J, Copland, C, Kerloeguen, Y, Norga, K, Pacaud, L, Sevaux, M -A, Spadoni, C, Sterba, J, Ligas, F, Taube, T, Uttenreuther-Fischer, M, Chioato, S, O'Connell, M A, Geoerger, B, Blay, J -Y, Soria, J C, Kaye, S, Wulff, B, Brugières, L, Vassal, G, Pearson, A D J
Publicado no Ann Oncol (2018)